Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Inventory (2016 - 2026)

Cumberland Pharmaceuticals' Inventory history spans 16 years, with the latest figure at $6.2 million for Q4 2025.

  • On a quarterly basis, Inventory rose 55.64% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.2 million, a 55.64% increase, with the full-year FY2025 number at $6.2 million, up 55.64% from a year prior.
  • Inventory hit $6.2 million in Q4 2025 for Cumberland Pharmaceuticals, up from $2.9 million in the prior quarter.
  • Over the last five years, Inventory for CPIX hit a ceiling of $10.9 million in Q2 2023 and a floor of $2.9 million in Q3 2025.
  • Historically, Inventory has averaged $7.3 million across 5 years, with a median of $8.6 million in 2021.
  • Biggest five-year swings in Inventory: plummeted 60.63% in 2024 and later soared 55.64% in 2025.
  • Tracing CPIX's Inventory over 5 years: stood at $8.4 million in 2021, then rose by 17.01% to $9.9 million in 2022, then crashed by 53.27% to $4.6 million in 2023, then decreased by 13.22% to $4.0 million in 2024, then soared by 55.64% to $6.2 million in 2025.
  • Business Quant data shows Inventory for CPIX at $6.2 million in Q4 2025, $2.9 million in Q3 2025, and $3.2 million in Q2 2025.